Scaling At-home Infectious Disease Diagnostics: From Promise to Practice
The COVID-19 pandemic catalyzed the decentralization of diagnostics, bringing them into homes from lab floors. With the FDA approving at-home testing kits for STIs and respiratory infections, the infectious disease diagnostics market is embracing its watershed moment. It is slated to reach $46.05 billion by 2032 at an implied CAGR of 7.89%. Currently, at-home diagnostic […]